abstract |
The present invention relates to an ophthalmic aqueous solution for treating ocular hypertension and glaucoma, comprising PGF2α analogue as an active ingredient, wherein said ophthalmic aqueous solution contains nonionic surfactant, stabilizing agent and substantially no preservatives in a container consisting essentially of polyethylene; and the polyethylene is low density polyethylene (LDPE). |